Generic placeholder image

Current Drug Targets


ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

How to Manage Pouchitis in Ulcerative Colitis?

Author(s): F. Magro, S. Lopes, S. Rodrigues and I. Azevedo

Volume 12, Issue 10, 2011

Page: [1454 - 1461] Pages: 8

DOI: 10.2174/138945011796818144

Price: $65


It is estimated that 50% of patients who have undergone ileal pouch – anal anastomosis (IPAA) surgery for UC will develop at least one episode of pouchitis. The risk of developing pouchitis is much higher in patients with preoperative extraintestinal manifestations and primary sclerosing cholangitis. In acute pouchtis metronidazole or ciprofloxacin have shown efficacy, however there is some evidence that ciprofloxacin may have better and has less toxic. In patients with chronic pouchitis antibiotics are less effective, and maintenance therapy may be required. In cases of refractoriness to conventional therapy a combination of two antibiotics for a prolonged period or infliximab may be effective. Starting maintenance treatment with highly concentrated probiotics is recommended as primary and secondary prophylaxis.

Keywords: Pouchitis, Antibiotics, Treatment, Probiotics, Tumor Necrosis Factor, Sulfate reducing bacteria, ESBL, Azathioprine

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy